Award
National Cancer Institute 5R33CA291185-02
Quantification of molecular interactions across the matrix spectrum enables cancer research.
Recipient
Vanderbilt University
Award Amount
$338,041.00
Ceiling
$338,041.00
Awarded
August 22, 2025
Identifier
5R33CA291185-02
This award supports the development of a novel molecular interaction technology (FSA-CIR) to advance cancer research by enabling sensitive, label-free assays across diverse biological matrices, facilitating early detection and clinical diagnosis.
Description
Development, refinement, and validation of free-solution assay (FSA) technology and compensated Interferometric reader (CIR) for cancer research, enabling label-free, solution-phase, ultra-sensitive molecular interaction analysis across various matrices to improve early detection, clinical diagnosis, and biochemical mechanism of action studies.